SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 1

Clinical features of infants treated for severe retinopathy of prematurity: 8-yearstudy from a large tertiary neonatal intensive care unit in Turkey

Özdemir ÖZDEMİR
İkbal Seza PETRİÇLİ
Zühal ÖZEN TUNAY
Damla ERGİNTÜRK ACAR
Şerife Suna OĞUZ
Pages
42–47
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Infants with severe ROP had a wider range of BWs and GAs compared to those from developed countries and earlier treatment was needed for out-born infants.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of this study was to report the gestational age (GA) and birth weight (BW) distribution of premature babies who needed treatment for retinopathy of prematurity (ROP) and to assess the timing of the treatment.
📊
Key Findings & Data:Materials and methods: The records of 9008 infants who were screened for ROP were examined and 556 infants who underwent laser therapy for ROP were reviewed.
💡
Conclusion & Impact:Conclusion: Infants with severe ROP had a wider range of BWs and GAs compared to those from developed countries and earlier treatment was needed for out-born infants.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The aim of this study was to report the gestational age (GA) and birth weight (BW) distribution of premature babies who needed treatment for retinopathy of prematurity (ROP) and to assess the timing of the treatment. Materials and methods: The records of 9008 infants who were screened for ROP were examined and 556 infants who underwent laser therapy for ROP were reviewed. Sex, GA, BW, postnatal age, and postmenstrual (PM) age at the time of laser therapy were recorded. The babies were classified as in-born (Group 1) and out-born infants (Group 2). Results: The mean GA was 27.3 weeks (range: 22 33 weeks) and the mean BW was 991.1 g (range: 520 2160 g). Of the treated infants, 7.0% were born later than 32 weeks and 8.3% were born over 1500 g. The mean postnatal age was 9.48 weeks (range: 5 22 weeks) and the mean PM age was 36.72 weeks (range: 29 48 weeks) at the time of treatment. Mean BWs and GAs were significantly higher and the mean postnatal age at the time of laser therapy was significantly earlier in Group 2. Conclusion: Infants with severe ROP had a wider range of BWs and GAs compared to those from developed countries and earlier treatment was needed for out-born infants.

🔖

Cite This Article

ÖZDEMİR, Ö., PETRİÇLİ, İ. S., TUNAY, Z. Ö., ACAR, D. E., OĞUZ, Ş. S. (2022). Clinical features of infants treated for severe retinopathy of prematurity: 8-yearstudy from a large tertiary neonatal intensive care unit in Turkey. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 1, 42–47. https://ajindex.com/articles/611112

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sarikabadayi YU, Aydemir O, Ozen ZT, Aydemir C, Tok L, Oguz SS, Erdeve O, Uraş N, Dilmen U. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors. Ophthalmic Epidemiol 2011; 18: 269–274
  2. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84: 77–82
  3. Gilbert C, Foster A. Childhood blindness in the context of VISION 2020: the right to sight. Bull World Health Organ 2001; 79: 227–232
  4. Erdeve Ö, Atasay B, Arsan S, Batıoğlu F, Atilla H, Türmen T. Restricted universal guidelines for ROP screening: a possible misguidance for middle income countries. Turk J Med Sci 2010; 40: 791–796
  5. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013; 131: 189–195
  6. Fielder AR, Haines L, Scrivener R, Wilkinson AR, Pollock JI; Royal Colleges of Ophthalmologists and Paediatrics and Child Health; the British Association of Perinatal Medicine. Retinopathy of prematurity in the UK II: audit of national guidelines for screening and treatment. Eye 2002; 16: 285–291
  7. Jefferies AL. Retinopathy of prematurity: Recommendations for screening. Paediatr Child Health 2010; 15: 667–670
  8. Early Treatment for Retinopathy of Prematurity Cooperative Group. Results of the early treatment for retinopathy of prematurity randomized trial: revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2003; 121: 1684–1696
  9. Blencowe H, Lawn JE, Vazquez T, Fielders A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013; 74: 35–49
  10. Amer M, Jafri WH, Nizami AM, Shomrani AI, Al-Dabaan AA, Rashid K. Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity? Br J Ophthalmol 2012; 96: 1052–1055
  11. Hungi B, Vinekar A, Datti N, Kariyappa P, Braganza S, Chinnaiah S, Donthi K, Shetty B. Retinopathy of prematurity in a rural neonatal intensive care unit in South India—A prospective study. Indian J Pediatr 2012; 79: 911–915
  12. Adio AO, Ugwu RO, Nwokocha CG, Eneh AU. Retinopathy of prematurity in Port Harcourt, Nigeria. ISRN Ophthalmology 2014; 2014: 481527–481533
  13. Akman